2340432-40-6
Chemical Structure
Pparδ agonist 7
- CAS No.: 2340432-40-6
- Formula:C25H25NO5
- Molecular Weight:419.47
IUPAC Name: (E)-2-(4-(3-(2-methoxyquinolin-3-yl)-3-oxoprop-1-en-1-yl)-2,6-dimethylphenoxy)-2-methylpropanoic acid
InChIKey: WKIFJBLRQMGCTO-ZHACJKMWSA-N
SMILES: CC(C)(OC1=C(C)C=C(/C=C/C(C2=CC3=CC=CC=C3N=C2OC)=O)C=C1C)C(O)=O
Biological Activity: Pparδ agonist 7 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 7 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2019105234A1, compound TM4)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pparδ agonist 7 | Pparδ agonist 7 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 7 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2019105234A1, compound TM4). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
